My ePortfolio Register   

WIN 2011 /
Importance and impact of the WIN Symposium

6th - 7th Jul 2011

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.07.11
Views: 4473

Prof Alexander Eggermont – Gustave Roussy Cancer Institute, Paris, France

Prof Eggermont explains WIN and its mission within the cancer community, as well as its current impact and hopes for personalised cancer medicine. Discussion on cell genetic changes and the genetic backgrounds of the person contribute to targeted therapies allow a for greater development in research. With WIN’s emphasis on being a world-wide organisation, Prof Eggermont highlights how this will produce new drugs and discoveries in both the western and non-western world, ultimately from pharma, institutes, and biotech working in a unique partnership.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence